The Development and Maintenance of Human Visceral Pain Hypersensitivity is Dependent on the N-methyl-D-aspartate Receptor
Overview
Authors
Affiliations
Background & Aims: Visceral hypersensitivity is a common feature of functional gastrointestinal disorders. One speculated mechanism is an activity-dependent increase in spinal cord neuronal excitability (central sensitization), which is dependent on activation of the N-methyl-D-aspartate (NMDA) receptor. Our aims were to determine whether the development and maintenance of human visceral hypersensitivity is NMDA receptor mediated.
Methods: Healthy subjects were studied using a randomized, double-blind, placebo-controlled, crossover design. Pain thresholds to electrical stimulation were determined both in the proximal esophagus and in the foot (control) before and after a 30-minute distal esophageal infusion of 0.15 mol/L HCl acid. Ketamine (NMDA receptor antagonist) or saline (vehicle) was given intravenously either prior to or following acid infusion, and pain thresholds were measured for the following 120 minutes. Protocol 1: In 6 subjects, the effect of ketamine in the esophagus was assessed without acid infusion. Protocol 2: In 14 subjects, ketamine was given prior to esophageal acid. Protocol 3: In 12 subjects, ketamine was given after esophageal acid.
Results: Protocol 1: In the absence of esophageal acid, ketamine had no effect on either esophageal or foot pain thresholds (area-under-the-curve, [AUC] P = 0.36 esophagus, P = 0.34 foot, ANOVA) within 30 minutes of cessation of the infusion. Protocol 2: Acid-induced esophageal hypersensitivity was prevented by ketamine (AUC, P < 0.0001, ANOVA) without affecting foot pain thresholds (AUC, P = 0.06, ANOVA). Protocol 3: Ketamine delivered after acid reversed the induction of esophageal hypersensitivity induced by acid (AUC, P < 0.0001, ANOVA).
Conclusions: The induction and maintenance of acid-induced esophageal hypersensitivity is prevented and reversed by ketamine. This finding strongly indicates that central sensitization is a mechanism of visceral hypersensitivity.
Ten Barge J, van den Bosch G, Slater R, van den Hoogen N, Reiss I, Simons S Paediatr Drugs. 2025; 27(2):201-220.
PMID: 39752054 PMC: 11829917. DOI: 10.1007/s40272-024-00676-0.
Tahir A, Ding Y, Wan J, Shah M, Janyaro H, Li X Heliyon. 2024; 10(23):e40700.
PMID: 39717594 PMC: 11665384. DOI: 10.1016/j.heliyon.2024.e40700.
Chronic abdominal pain in inflammatory bowel disease: a practical guide.
Baillie S, Norton C, Saxena S, Pollok R Frontline Gastroenterol. 2024; 15(2):144-153.
PMID: 38420131 PMC: 10897648. DOI: 10.1136/flgastro-2023-102471.
Opioid Sparing Analgesics in Spine Surgery.
Reed L, Patel M, Luque K, Theiss S Adv Orthop. 2022; 2022:1026547.
PMID: 35942400 PMC: 9356873. DOI: 10.1155/2022/1026547.
Furst P Life (Basel). 2022; 12(5).
PMID: 35629347 PMC: 9143404. DOI: 10.3390/life12050679.